Sprim
Private Company
Funding information not available
Overview
Sprim is a unique, integrated player in the life sciences ecosystem, functioning both as a full-service consulting firm and a strategic investor. Through its SPRIM Health Group, it provides end-to-end services from innovation strategy and clinical trial execution to regulatory navigation and marketing. Concurrently, its investment arm, SPRIM Global Investments, provides capital and operational support to clinical-stage biotech and late-stage medtech companies, creating a synergistic model that de-risks and accelerates health innovation.
Technology Platform
Integrated digital health and AI toolkit for clinical trials, including the ObvioHealth platform for decentralized trials, algorithm-based patient screening, and behavioral modules for recruitment and compliance.
Opportunities
Risk Factors
Competitive Landscape
Sprim competes with large global CROs (e.g., IQVIA, Parexel) and strategy consultancies in life sciences, as well as niche digital health CROs. Its hybrid consulting-investment model is a key differentiator, but it must contend with specialized venture capital firms and more traditional service providers on either side of its business.